28th Jul 2017 3:51 pm |
RNS |
Director/PDMR Shareholding |
26th Jul 2017 1:22 pm |
RNS |
Director/PDMR Shareholding |
26th Jul 2017 12:41 pm |
RNS |
Director/PDMR Shareholding - Replacement |
26th Jul 2017 11:00 am |
RNS |
Half-year Report |
25th Jul 2017 1:30 pm |
RNS |
ViiV announces results from NEAT 022 study |
25th Jul 2017 1:30 pm |
RNS |
ViiV announces positive results from DAWNING |
24th Jul 2017 9:02 am |
RNS |
LATTE-2 phII results presented at IAS in Paris |
21st Jul 2017 3:34 pm |
RNS |
Director/PDMR Shareholding |
21st Jul 2017 3:30 pm |
RNS |
Director/PDMR Shareholding |
21st Jul 2017 1:59 pm |
RNS |
GSK submits EU filing for Relvar Ellipta extension |
21st Jul 2017 11:00 am |
RNS |
Directorate Change |
17th Jul 2017 6:08 pm |
RNS |
Director/PDMR Shareholding |
17th Jul 2017 5:44 pm |
RNS |
Director/PDMR Shareholding |
14th Jul 2017 4:58 pm |
RNS |
Director/PDMR Shareholding |
14th Jul 2017 4:46 pm |
RNS |
Director/PDMR Shareholding |
14th Jul 2017 4:02 pm |
RNS |
Director/PDMR Shareholding |
14th Jul 2017 11:57 am |
RNS |
Director/PDMR Shareholding |
12th Jul 2017 4:12 pm |
RNS |
Director/PDMR Shareholding |
3rd Jul 2017 10:05 am |
RNS |
Total Voting Rights |
28th Jun 2017 4:13 pm |
RNS |
GSK announces US filing for mepo in EGPA |
27th Jun 2017 10:06 am |
RNS |
GSK starts phIII study on mepo for nasal polyps |
21st Jun 2017 2:35 pm |
RNS |
Director/PDMR Shareholding |
21st Jun 2017 2:05 pm |
RNS |
GSK presents Shingrix PhIII study results at ACIP |
19th Jun 2017 4:29 pm |
RNS |
GSK confirms start date for Luke Miels |
12th Jun 2017 4:43 pm |
RNS |
Director/PDMR Shareholding |
5th Jun 2017 5:23 pm |
RNS |
Director/PDMR Shareholding |
2nd Jun 2017 7:00 am |
RNS |
ViiV submits first 2-drug HIV regimen application |
1st Jun 2017 10:58 am |
RNS |
Total Voting Rights |
31st May 2017 4:25 pm |
RNS |
Director/PDMR Shareholding |
22nd May 2017 4:45 pm |
RNS |
Director/PDMR Shareholding |
22nd May 2017 4:40 pm |
RNS |
Director/PDMR Shareholding |
22nd May 2017 2:23 pm |
RNS |
Ph3 MUSCA study presented at ATS |
18th May 2017 7:00 am |
RNS |
NEJM publication of PH3 study into Mepo in EGPA |
12th May 2017 4:26 pm |
RNS |
Block listing Interim Review |
11th May 2017 5:29 pm |
RNS |
Director/PDMR Shareholding |
10th May 2017 4:26 pm |
RNS |
Headline Phase III results: Mepo in COPD |
5th May 2017 12:39 pm |
RNS |
Rellvar Ellipta 2nd Salford Lung Study Results |
4th May 2017 6:10 pm |
RNS |
Result of AGM |
2nd May 2017 1:02 pm |
RNS |
Director/PDMR Shareholding |
2nd May 2017 10:02 am |
RNS |
Total Voting Rights |